Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.03 USD | +0.05% | -3.33% | -33.47% |
Jun. 03 | Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses | MT |
Jun. 01 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.47% | 7.29B | |
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Expects to Log Profit in 2026